Publications by authors named "Saeed Fatenejad"

Claim this Profile
O
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment.
Eugen Feist, Roy M Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin

Ann Rheum Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study.
Eugen Feist, Saeed Fatenejad, Sergey Grishin, Elena Korneva, Michael E Luggen

Ann Rheum Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Josef S Smolen, Eugen Feist, Saeed Fatenejad, Sergey A Grishin, Elena V Korneva

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.
Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist, Mariana Ivanova, Elena Korneva

Ann Rheum Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated population pharmacokinetics of etanercept in healthy subjects and in patients with rheumatoid arthritis and ankylosing spondylitis.
Simon Y Zhou, Cathye Shu, Joan Korth-Bradley, Donald Raible, Maria Palmisano, Saeed Fatenejad

J Clin Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.
Ganesh Raghu, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Roland M du Bois, Saeed Fatenejad

Am J Respir Crit Care Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Robert Landewé, Désirée van der Heijde, Lars Klareskog, Ronald van Vollenhoven, Saeed Fatenejad

Arthritis Rheum· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Désirée van der Heijde, Lars Klareskog, Vicente Rodriguez-Valverde, Catalin Codreanu, Horatiu Bolosiu, Saeed Fatenejad

Arthritis Rheum· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.
Désirée van der Heijde, Robert Landewé, Lars Klareskog, Vicente Rodríguez-Valverde, Lucas Settas, Saeed Fatenejad

Arthritis Rheum· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Honghui Zhou, Philip R Mayer, Joseph Wajdula, Saeed Fatenejad

J Clin Pharmacol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lars Klareskog, Désirée van der Heijde, Julien P de Jager, Andrew Gough, Joachim Kalden, Saeed Fatenejad

Lancet· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis